Skip to content
‹ Back to IndustriesHealthcare

Nearly 500 hospitals track shortage-affected segments via RFID

According to Bluesight, nearly 500 hospitals track almost 4,000 shortage-affected medication segments in their RFID systems. Checks of cabinets and carousels have been missing that RFID-tracked supply. Gilman argues that bringing RFID data in next to cabinet data gives more complete usage rates and days-on-hand calculations, though the gain could depend on whether systems connect at the transaction level.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · BluesightKitcheckShortagecheckRfid
Share
Nearly 500 hospitals track shortage-affected segments via RFID

Key takeaways

01

During a shortage, a count that stops at the dispensing cabinet can get both stock on hand and usage rate wrong, which is how hospitals end up placing emergency orders they may not need.

02

RFID is no longer limited to kit and tray management: nearly 500 hospitals already track almost 4,000 shortage-affected medication segments in their RFID systems.

03

For operators weighing a merged feed, the key question could be whether RFID usage flows into the days-on-hand calculation at the transaction level or sits beside cabinet data as a static count.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

When a drug goes short, most hospital pharmacy teams check the automated dispensing cabinet first. Those teams manage inventory across central pharmacies, operating rooms, infusion centers, clinics and satellite locations, and the cabinet view has been missing a meaningful share of the total medication supply: everything tracked with RFID.

Sean Gilman takes up that gap in a November 4 editorial in RXinsider. The scale is what stands out. According to Bluesight, nearly 500 hospitals already track shortage-affected medication segments in their RFID systems, almost 4,000 segments in total, and manage them with temporary PAR levels and acceptable alternatives.

So the data exists. What matters to a director of pharmacy or a health-system supply chain lead is whether it shows up in the number they use to decide on an emergency order.

Where the uncounted stock sits

Hospital pharmacies hold medication across central pharmacies, ORs, infusion centers, clinics and satellite locations, Gilman writes, and the cabinet data and the RFID data have historically lived in separate systems. In a shortage, someone has to reconcile them by hand, and that cross-referencing can eat hours of skilled pharmacy time. Skipping it has a cost too. A count that misses RFID stock makes supply look thinner than it is, which the editorial ties to a false sense of urgency and wasteful emergency purchases.

Taken together, the figures suggest the RFID systems hospitals built for kit and tray management have become a second inventory that the shortage workflow hasn't been reading. Gilman argues RFID has moved past kits and trays into active shortage response across the pharmacy enterprise. The Bluesight segment count backs him up: hospitals are already setting shortage rules inside these systems.

From tray accuracy to days on hand

Readers extract unique identifiers from tags by emitting radio waves, without needing a line of sight, and multiple tags can be read at the same time. That could make checking a full tray much faster than scanning items one at a time.

Those are counting wins. Shortage response asks the data for something harder: how fast a drug is moving and how much buffer is left. Gilman's case is that when RFID unit totals, location counts and usage patterns flow in next to cabinet data, the usage rate reflects consumption across the whole system instead of cabinet activity alone. During a shortage, a count that stops at the dispensing cabinet can get both halves of the days-on-hand math wrong: how much stock is on hand and how fast it is being used.

The gain is largest where stock is spread out. For a health system whose RFID footprint is concentrated in those settings, each new deployment adds stock that shortage planners can see. A system that uses RFID only for a handful of crash-cart kits would likely see a smaller change.

A PAR (periodic automatic replenishment) level is the stocking target for a given location. During shortages, the hospitals Bluesight counts set temporary PAR levels for affected segments and pair them with acceptable alternatives. That is the workflow merged RFID data feeds.

Tags, standards and who can read them

Intelliguard, an RFID medication management company, notes that hospitals can partner with drug manufacturers like Fresenius Kabi and Cencora to purchase pre-tagged or source-tagged medications. That approaches Gilman's argument from the analytics side. For procurement teams, source tagging could decide how much of the inventory ends up visible without pharmacy staff tagging it by hand.

Tag frequency is another spec-sheet choice. TSC argues high-frequency RFID suits pharmacy shelves better than the UHF, or RAIN, tags common in logistics: short-range HF reads hold up around metal racks, liquid-filled vials and foil-backed packs, and pick up only the item in front of the reader. Those claims come from a vendor.

Where a merged feed still falls short

The strongest caution comes from a narrative review in the International Journal of Scientific Research and Technology by independent researcher Samiyullaha Sayyed. It asks why automated hospital pharmacies still find gaps between perpetual inventory and physical stock, and two of its five causes bear directly on this idea. Systems are often connected at the interface level but not the transaction level, so data from cabinets, ERP, the EHR and wholesalers arrives late and in pieces. And human handling, including borrowing, waste, returns and multi-step dispensing, happens where automation can't fully see it, a limit the review says also applies to some RFID deployments.

In the case evidence Sayyed reviews, RFID and dispensing-cabinet deployments improved accuracy and time-to-restock but did not eliminate discrepancies. Lasting gains, the review argues, need transaction-level data governance, verification at every physical handoff and clear ownership of exceptions. That doesn't undercut Gilman's case. It sets the bar: a merged RFID and cabinet count is only as good as the handoffs feeding both.

Ask whether RFID usage flows into the shortage tool's usage rate and days-on-hand calculation, or only appears as a static count next to the cabinet numbers. The review's line between interface-level and transaction-level integration decides which one a hospital gets.

For operators, one number to watch could be the share of facilities planning to implement RFID within the next 12 months. Each rollout that lands in an infusion center or surgery center adds stock to the shortage picture, but only if the shortage workflow reads it.

Featured companies

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

New York City digital health startups raised $1.9 billion in Q3, up 36%

New York City digital health startups raised $1.9 billion in Q3, up 36%

New York City digital health startups raised $1.9 billion in Q3 2026, up 36% year over year. Nationally, Rock Health counted $3.7 billion raised by U.S. digital health startups across 114 deals in the quarter. Bigger checks and steady acquisitions mean buyers must assess which vendors are pulling ahead—and which may change owners mid-rollout.

  • 01New York's digital health startups grew Q3 funding 36% year over year, while U.S. digital health startups raised $3.7 billion across 114 deals in Q3, according to Rock Health.
  • 02Average U.S. digital health deal size has climbed from $20.6 million in 2024 to $31.0 million so far in 2026, so more of the money is going into bigger rounds.
  • 03Acquisition is still how most digital health companies exit, with 164 deals through Q3 2026 and no new public listings since August 2025. That makes a vendor's change-of-ownership terms a live contract question for buyers.

Nov 4, 2026

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS said on November 3 it acquired LookDeep Health, a computer vision company, and introduced iQueue for Virtual Care, its first product built on what it calls ambient intelligence. Terms were not disclosed. The product bundles Virtual Observation, Virtual Nursing and Virtual Medicine, and LeanTaaS says hospitals can build on compatible cameras and in-room devices already installed or deploy supported hardware. The company cited reported results from LookDeep deployments, including fall-rate reductions of more than 70%, and said LookDeep's technology was evaluated in peer-reviewed research published in Frontiers in Imaging.

  • 01LeanTaaS acquired LookDeep Health and launched iQueue for Virtual Care, combining Virtual Observation, Virtual Nursing and Virtual Medicine; acquisition terms were not disclosed.
  • 02Hospitals can build on compatible cameras and in-room devices already in place or deploy supported hardware, according to LeanTaaS, which did not name camera vendors.
  • 03LeanTaaS reported results from LookDeep deployments including fall-rate reductions of more than 70% and twice as much nursing contact, figures that are the company's own and not tied to named health systems.

Nov 3, 2026

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Royal Philips reported 8% comparable order intake growth for the third quarter of 2026, driven by Diagnosis & Treatment, with comparable sales up 3% to EUR 4.4 billion and an adjusted EBITA margin of 13.0%, up 70 basis points. The company reiterated its 2026 outlook for 3% to 4.5% comparable sales growth. Philips Respironics reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations related to its recall, and Philips recorded a EUR 288 million provision in the quarter, with payment expected in the first quarter of 2027 subject to final documentation.

  • 01Comparable order intake grew 8%, matching a year earlier, with Diagnosis & Treatment the driver; the equipment order book stands at about 40% of revenue.
  • 02Comparable sales rose 3% to EUR 4.4 billion, adjusted EBITA margin reached 13.0%, and free cash flow was EUR 384 million; the 2026 outlook was reiterated.
  • 03Philips Respironics reached an agreement in principle with the DOJ on previously disclosed recall investigations, and Philips recorded a EUR 288 million provision; the settlement is subject to final documentation.

Nov 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512